The development of new drugs with potential therapeutic applications is one of the most complex and difficult process in the pharmaceutical industry. Millions of dollars and man-hours are devoted to the discovery of new therapeutical agents. Recently, impressive technological advances in areas such as structural characterization of molecules, computer sciences and molecular biology have made rational drug design feasible. The Protein- Ligand interaction plays a significant role in structural based drug designing. Chalcones and their derivates have been shown to have potency as anticancer. Chalcone is a flavonoid compound, analogs of this drug molecule were selected from published journals and docked with COX-1 (PDB ID: ICQE) using HEX software. Furthermore, these docking processes were obtained the lowest scoring value in chalcone-30. The substituent compatibility and then ADME properties of the Analogs was analyzed using Insilico. Analysis of the results of the docking softwares suggested that chalcone-30 can act as a potent COX-1 inhibitor, than the screened 50 chalcones.
